STOCK TITAN

BioMarin to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call and Webcast on Thursday, February 25 at 4:30pm ET

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) announced a conference call scheduled for February 25, 2021, at 4:30 p.m. ET. CEO Jean-Jacques Bienaimé will discuss the company's fourth quarter and full year 2020 financial results alongside a business update. The call can be accessed via a live audio webcast on the BioMarin website. For U.S. participants, the dial-in number is (866) 502-9859, while international participants can dial (574) 990-1362, using Conference ID 6488682.

Positive
  • Scheduled conference call may indicate an upcoming positive financial update.
  • Live audio webcast increases accessibility for investors.
Negative
  • None.

SAN RAFAEL, Calif., Jan. 26, 2021 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin, will host a conference call and webcast on Thursday, February 25, at 4:30 p.m. ET to discuss fourth quarter and full year 2020 financial results and provide a general business update.

Dial-in Number 
U.S. / Canada Dial-in Number: (866) 502-9859
International Dial-in Number: (574) 990-1362
Conference ID: 6488682

Replay Dial-in Number: (855) 859-2056
Replay International Dial-in Number: (404) 537-3406
Conference ID: 6488682

Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website, www.biomarin.com. A replay of the call will be archived on the site for one week following the call.

About BioMarin
BioMarin is a global biotechnology company that develops and commercializes innovative therapies for patients with serious and life-threatening rare genetic diseases. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.  For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.

Contacts:


Investors

Media

Traci McCarty

Debra Charlesworth

BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc.

(415) 455-7558

(415) 455-7451

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/biomarin-to-host-fourth-quarter-and-full-year-2020-financial-results-conference-call-and-webcast-on-thursday-february-25-at-430pm-et-301214639.html

SOURCE BioMarin Pharmaceutical Inc.

FAQ

When will BioMarin announce its fourth quarter and full year 2020 financial results?

BioMarin will announce its financial results on February 25, 2021.

What time is the BioMarin conference call?

The conference call is scheduled for 4:30 p.m. ET on February 25, 2021.

How can I listen to the BioMarin financial results webcast?

The webcast can be accessed via the investor section of the BioMarin website.

What is the dial-in number for the BioMarin conference call?

The U.S. dial-in number is (866) 502-9859, and the international dial-in number is (574) 990-1362.

Is there a replay available for the BioMarin conference call?

Yes, a replay will be available after the call via the same dial-in numbers.

BioMarin Pharmaceuticals Inc

NASDAQ:BMRN

BMRN Rankings

BMRN Latest News

BMRN Stock Data

13.24B
188.89M
0.88%
97.54%
2.82%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
NOVATO